Chimamanda's Son's Death: Pharmacists Demand Urgent Probe, Highlighting Propofol Risks and Governance Gaps
The tragic death of Nkanu, the young son of renowned writer Chimamanda Ngozi Adichie, has sparked a critical call to action from the Association of Hospital and Administrative Pharmacists of Nigeria (AHAPN). In a statement, AHAPN warns of a grave patient-safety breach, emphasizing the need for urgent national accountability and a thorough investigation.
The incident, according to AHAPN's National Chairman, Pharm. Elechi Oyim, reveals a serious deviation from internationally accepted standards of pediatric anesthesia and medication safety. The administration of propofol, a sedative, to a child under three years old is a major concern, as it contradicts established global guidelines.
"Propofol Infusion Syndrome (PRIS) is a critical complication associated with high morbidity and mortality, particularly in young children," Oyim explained. "International standards clearly warn against prolonged propofol use due to its severe risks."
Global health organizations, including the World Health Organization (WHO), the U.S. Food and Drug Administration (FDA), and leading British anesthesia institutions, have issued repeated warnings against such practices in pediatric intensive care. The FDA, in particular, emphasizes that propofol is not approved for long-term sedation in these units due to the multiple fatalities linked to PRIS.
Beyond the clinical implications, the case highlights deeper weaknesses in Nigeria's healthcare governance structure. Oyim argues that the exclusion of pharmacists from medication decisions, especially in anesthesia and pediatric care, constitutes a systemic governance failure. He emphasizes the importance of clinical pharmacists in detecting unsafe drug choices, monitoring dosages, and preventing fatal outcomes.
"Medication safety is a shared responsibility," Oyim stated. "High-risk drugs like anesthetics require structured multidisciplinary oversight to ensure patient safety."
AHAPN calls for a transparent, independent investigation into Nkanu's death, urging urgent reforms to strengthen multidisciplinary medication governance in Nigerian hospitals. They emphasize the need to protect pediatric patients, who are legally and ethically protected from avoidable pharmacological risks.
"Failure to enforce international safety standards not only endangers lives but also increases institutional and legal liability," Oyim warned. "We must prioritize collaborative accountability in healthcare delivery to prevent such tragic losses."
Expressing sympathy to the bereaved family, Oyim concluded: "On behalf of AHAPN, we extend our deepest condolences to Chimamanda and her family. This loss is a stark reminder of the critical need for improved patient safety and governance in our healthcare system."
